Table 1. Systematic review characteristics and quality, with number of included and non-included RCTs.
Systematic review | Pop. | Intervention (vs comparison) | Search | RCTs | Qual. | Non-includ. RCTs | ||
---|---|---|---|---|---|---|---|---|
PD* | S^ | T# | ||||||
1. Airway, ventilation and oxygenation strategies | ||||||||
Hyperbaric hyperoxia | ||||||||
McDonough 2004[33] | All | Hyperbaric oxygen therapy** | 2003 | 2 | Mod | 3 | 1 | 1 |
§Meyer 2010[31] | All | Hyperbaric oxygen therapy | 1980–2008 | 2 | Mod | 3 | 1 | 1 |
§Lu 2012[19] | Adult | Hyperbaric oxygen therapy | 2011 | 2 | Low | 1 | 2 | 2 |
Bennett 2012[34] | All | Hyperbaric oxygen therapy | 2012 | 5 | High | 1 | 1 | 0 |
Hyperventilation | ||||||||
§Roberts 1998[32] | All | Hyperventilation vs. normovent. | 1996 | 1 | Low | 0 | 0 | 0 |
Roberts 1997[35] | All | Hyperventilation | 2008 | 1 | Mod | 0 | 0 | 0 |
§Meyer 2010[31] | All | Hyperventilation | 1980–2008 | 1 | Mod | 0 | 0 | 0 |
§Lu 2012[19] | Adult | Hyperventilation | 2011 | 1 | Low | 0 | 0 | 0 |
Management guided by brain tissue oxygen | ||||||||
Nangunoori 2012[36] | All | PbtO2-based vs ICP/CPP-based** | 1993–2010 | 0 | Low | 0 | 5 | 0 |
Lazaridis 2014[37] | Adult | Monitoring (≥ 2: PbtO2, PRx, LPR)** | 2013 | 4 | Mod | 0 | 1 | 0 |
2. Fluid management | ||||||||
Blood or blood product transfusion | ||||||||
Nishijima 2012[38] | Adult | Platelet transfusion | 2011 | 0 | Mod | 0 | 3 | 0 |
†Boutin 2015[39] | Adult | RBC transfusion | 2015 | 2 | High | 0 | 1 | 0 |
3. Hypothermia | ||||||||
Hypothermia | ||||||||
Harris 2002[40] | Adult | Hypothermia vs. normo.** | ?2001 | 7 | Mod | 14 | 11 | 4 |
McIntyre 2003[41] | Adult | Hypothermia vs. normo.** | 2002 | 11 | High | 13 | 11 | 1 |
Henderson 2003[42] | All | Hypothermia** | 2002 | 8 | Mod | 21 | 5 | 2 |
Peterson 2008[43] | Adult | Hypothermia vs. SC | 2007 | 12 | Mod | 10 | 6 | 8 |
†Saxena 2008[44] | All | Hypothermia min. 35◦ C | 2008 | 0 | High | 0 | 36 | 0 |
Sydenham 2009[45] | All | Hypothermia max. 35◦ C | 2009 | 20 | High | 10 | 5 | 1 |
§Meyer 2010[31] | All | Hypothermia | 1980–2008 | 9 | Mod | 12 | 5 | 10 |
Fox 2010[46] | Adult | Early hypothermia vs normo.** | ?2008 | 11 | High | 5 | 18 | 2 |
Sadaka 2012[47] | Adult | Hypothermia** | 2010 | 8 | Low | 7 | 19 | 2 |
Georgiou 2013[48] | All | Systemic hypothermia** | 2011 | 17 | High | 5 | 13 | 1 |
†Harris 2012[49] | Adult | Non-invasive head cooling | 2011 | 1 | High | 0 | 35 | 0 |
§Lu 2012[19] | Adult | Hypothermia | 2011 | 8 | Low | 5 | 5 | 18 |
Ma 2013[48] | Paed. | Hypothermia vs normo.** | ?2012 | 3 | Mod | 2 | 31 | 0 |
Crossley 2014[50] | Adult | Hypothermia** | 2012 | 15 | High | 1 | 18 | 2 |
Li 2014[51] | Adult | Moderate hypothermia | 2012 | 11 | Mod | 1 | 19 | 5 |
Madden 2015[52] | Adult | Hypothermia** | 2009–2013 | 2 | Low | 1 | 33 | 0 |
Zhang 2015[53] | Paed. | Hypothermia** | 2014 | 4 | Mod | 1 | 31 | 0 |
4. Intracranial, Cerebral Perfusion and Blood Pressure management | ||||||||
Hypertonic saline and/or mannitol | ||||||||
§Roberts 1998[32] | All | Mannitol vs. no mannitol | 1996 | 1 | Low | 0 | 17 | 0 |
Banks 2008[54] | All | HTS | 2007 | 4 | Low | 0 | 14 | 0 |
§Meyer 2010[31] | All | Mannitol, and/or HTS | 1980–2008 | 10 | Low | 6 | 0 | 2 |
Wakai 2013[55] | All | Mannitol | 2009 | 4 | High | 2 | 12 | 0 |
Kamel 2011[56] | All | Mannitol vs. HTS** | 2010 | 1 | Mod | 2 | 14 | 1 |
§Lu 2012[19] | Adult | Mannitol, and/or HTS | 2011 | 5 | Low | 3 | 2 | 8 |
Rickard 2014[57] | Adult | Mannitol vs. HTS** | ?2012 | 3 | Mod | 0 | 14 | 1 |
Lourens 2014[58] | All | HTS vs. saline/Lactated Ringers** | 2011 | 3 | High | 1 | 13 | 1 |
Li 2015[59] | Adult | Mannitol vs. HTS** | 2014 | 3 | Mod | 0 | 15 | 0 |
Management guided by intracranial pressure | ||||||||
Mendelson 2012[60] | Adult | ICP-directed therapy ** | 2011 | 0 | Mod | 1 | 1 | 0 |
Sadaka 2013[61] | Adult | Placement of ICP monitors | 1993–2011 | 0 | Low | 0 | 2 | 0 |
Su 2014[62] | All | ICP-directed therapy | 2013 | 1 | Mod | 0 | 1 | 0 |
Yuan 2015[63] | Adult | ICP Monitoring** | 2013 | 1 | Mod | 0 | 1 | 0 |
†Forsyth 2015[64] | All | ICP-directed therapy | 2015 | 1 | High | 0 | 1 | 0 |
Cerebrospinal fluid drainage | ||||||||
§Roberts 1998[32] | All | CSF drainage vs no drainage | 1996 | 0 | Low | 1 | 0 | 0 |
§Meyer 2010[31] | All | CSF drainage | 1980–2008 | 1 | Mod | 0 | 0 | 0 |
Posture | ||||||||
Fan 2004[65] | All | Therapeutic body positioning** | 2003 | 1 | Low | 0 | 0 | 1 |
§Meyer 2010[31] | All | Adjusting head posture | 1980–2008 | 2 | Mod | 0 | 0 | 0 |
§Meyer 2010[31] | All | Body rotation | 1980–2008 | 0 | Mod | 0 | 2 | 0 |
Pressure: other | ||||||||
†Muzevic 2013[66] | All | The Lund concept | 2013 | 0 | High | 0 | 0 | 0 |
5. Nutrition and glucose management | ||||||||
Nutrition: timing, delivery route and nutritional elements | ||||||||
Krakau 2006[67] | Adult | Feeding timing, routes, content** | 1993–2003 | 8 | Mod | 8 | 5 | 1 |
Perel 2006 [68] | All | Feeding timing & routes | 2006 | 7 | High | 2 | 13 | 0 |
§Lu 2012[19] | Adult | Early nutritional support | 2011 | 3 | Low | 2 | 5 | 12 |
Wang 2013[69] | All | Feeding timing, routes, elements** | 2012 | 10 | High | 0 | 8 | 4 |
Wang 2015[70] | All | Sm. intestine vs gastric feeding** | 2013 | 3 | Mod | 0 | 18 | 1 |
Nutrition: Insulin | ||||||||
Lei 2012[71] | Adult | Tight vs. conv. glycaemic control | 2011 | 4 | Mod | 1 | 0 | 0 |
§Lu 2012[19] | Adult | Insulin therapy | 2011 | 3 | Low | 1 | 1 | 0 |
6. Pharmacological therapies not elsewhere defined | ||||||||
Progesterone | ||||||||
§Meyer 2010[31] | All | Progesterone | 1980–2008 | 2 | Low | 5 | 0 | 0 |
§Lu 2012[19] | Adult | Progesterone | 2011 | 2 | Low | 5 | 0 | 0 |
Ma 2012[47] | All | Progesterone vs. placebo | 2012 | 2 | High | 5 | 0 | 0 |
Wang 2015[72] | All | Progesterone** | 1980–2015 | 5 | High | 0 | 0 | 2 |
†Zeng 2015[73] | All | Progesterone | 2015 | 6 | High | 0 | 1 | 0 |
Bradykinin antagonists | ||||||||
§Meyer 2010[31] | All | Bradykinin antagonists | 1980–2008 | 3 | Low | 1 | 0 | 0 |
§Lu 2012[19] | Adult | Bradykinin antagonists | 2011 | 1 | Low | 0 | 1 | 2 |
Calcium channel blockers | ||||||||
Langham 2003[74] | All | Calcium channel blockers | 2005 | 4 | Mod | 0 | 0 | 0 |
§Lu 2012[19] | Adult | Calcium channel blockers | 2011 | 3 | Low | 0 | 0 | 1 |
Antifibrinolytic agents | ||||||||
Perel 2010[75] | All | Haemostatic agents | 2009 | 2 | High | 2 | 0 | 0 |
§Lu 2012[19] | Adult | Haemostatic agents | 2011 | 1 | Low | 1 | 0 | 2 |
†Zehtabchi 2014[76] | All | Tranexamic acid | 2014 | 2 | High | 0 | 2 | 0 |
†Ker 2015[77] | All | Antifibrinolytic agents | 2015 | 2 | High | 0 | 2 | 0 |
Monoaminergic agonists | ||||||||
Siddall 2005[78] | All | Methylphenidate | 2004 | 0 | Low | 0 | 0 | 0 |
§Meyer 2010[31] | All | Dopamine targeting agents** | 1980–2008 | 0 | Mod | 0 | 0 | 0 |
†Forsyth 2006[79] | All | Monoaminergic agonists | 2009 | 0 | High | 0 | 0 | 0 |
Frenette 2012[80] | All | Dopamine agonists | 2010 | 0 | Mod | 0 | 0 | 0 |
§Lu 2012[19] | Adult | Monoaminergic agonists | 2011 | 0 | Low | 0 | 0 | 0 |
Aminosteroids | ||||||||
†Roberts 1999[81] | All | Aminosteroid vs. Placebo | 2006 | 1 | High | 0 | 0 | 0 |
§Lu 2012[19] | Adult | Tirilazad | 2011 | 1 | Low | 0 | 0 | 0 |
Pharmacological therapies not elsewhere defined: various (single topic) | ||||||||
§Meyer 2010[31] | All | Dimethyl sulphoxide | 1980–2008 | 0 | Low | 0 | 0 | 0 |
§Lu 2012[19] | Adult | Pegogortein | 2011 | 1 | Low | 0 | 0 | 0 |
†Alali 2014[82] | Adult | Beta-blockers | 2013 | 1 | High | 0 | 0 | 0 |
Shen 2015[83] | All | Anticoagulants** | 2013 | 2 | Mod | 0 | 0 | 0 |
†Zeiler 2014[84] | All | Tromethamine** | 2014 | 3 | High | 0 | 0 | 0 |
Sanfilippo 2015[85] | Adult | Neuromuscular blocking agents | 2014 | 3 | Low | 0 | 0 | 0 |
7. Glutamate receptor antagonists | ||||||||
Magnesium | ||||||||
Arango 2008[86] | All | Magnesium vs. control | 2008 | 1 | High | 2 | 0 | 0 |
Li 2015[87] | All | Magnesium** | 2013 | 3 | Mod | 0 | 0 | 0 |
Glutamate receptor agonists: general | ||||||||
Willis 2003[88] | All | EAAI vs. control** | 2002 | 2 | High | 5 | 0 | 0 |
§Meyer 2010[31] | All | Cannabinoids | 1980–2008 | 2 | Low | 0 | 5 | 0 |
§Lu 2012[19] | Adult | EAAI | 2011 | 4 | Low | 1 | 0 | 2 |
8. Prehospital and systems of care | ||||||||
Prehospital intubation | ||||||||
§Lu 2012[19] | Adult | Pre-hospital RSI | 2011 | 1 | Low | 0 | 0 | 0 |
†Bossers 2015[89] | Adult | Prehospital intubation** | 2015 | 1 | High | 0 | 0 | 0 |
Specialist versus general hospital transfer or care | ||||||||
Pickering 2015[90] | All | Prehospital transfer strategies | 1998–2012 | 0 | Mod | 1 | 0 | 0 |
†Fuller 2014[91] | Adult | Specialist neuroscience care | 2013 | 0 | High | 0 | 1 | 0 |
9. Sedation, Pain management, Anaesthesia and Arousal | ||||||||
Sedative agents | ||||||||
§Meyer 2010[31] | All | Opiods, propofol, midazolam | 1980–2008 | 3 | Mod | 2 | 1 | 6 |
Roberts 2011[92] | All | Range of sedative agents | 2010 | 10 | High | 2 | 0 | 0 |
Gu 2014[93] | All | Midazolam vs. propofol | 2013 | 2 | Mod | 0 | 10 | 0 |
Ketamine | ||||||||
Zeiler 2014[94] | All | Ketamine** | 2013 | 2 | High | 1 | 0 | 0 |
Wang 2014[95] | All | Ketamine vs opiods** | 2014 | 2 | Mod | 0 | 0 | 1 |
Cohen 2015[87] | Adult | Ketamine** | 2014 | 3 | Mod | 0 | 0 | 0 |
Barbiturates | ||||||||
§Roberts 1998[32] | All | Barbiturates vs. no barbiturates | 1996 | 2 | Low | 0 | 5 | 2 |
§Meyer 2010[31] | All | Barbiturates | 1980–2008 | 3 | Low | 2 | 1 | 3 |
§Lu 2012[19] | Adult | Barbiturates | 2011 | 2 | Low | 1 | 1 | 5 |
Roberts 2012[96] | All | Barbiturates | 2012 | 6 | High | 0 | 1 | 2 |
Stimulation | ||||||||
§Meyer 2010[31] | All | Stimulation; sensory, electrical | 1980–2008 | 3 | Mod. | 1 | 0 | 0 |
†Wong 2013[97] | All | Acupuncture | 2012 | 0 | High | 0 | 0 | 0 |
Burst suppression | ||||||||
Zeiler 2015[98] | All | Burst suppression** | 2015 | 1 | High | 0 | 18 | 2 |
10. Seizure prophylaxis | ||||||||
Anti-epileptic agents | ||||||||
Schierhout 1998[99] | All | Anti-epileptic agents | 1996 | 4 | Mod | 5 | 3 | 1 |
Teasell 2007[100] | All | Any seizure interventions | 1980–2005 | 4 | Mod | 3 | 4 | 2 |
Zafar 2012[101] | All | Phenytoin vs. levetiracetam | 2011 | 0 | High | 0 | 12 | 1 |
Thompson 2015[102] | All | Anti-epileptic, neuroprot. agents** | 2015 | 8 | High | 1 | 4 | 0 |
11. Steroids | ||||||||
Corticosteroids | ||||||||
§Roberts 1998[32] | All | Corticosteroids vs. no corticost. | 1996 | 11 | Low | 2 | 3 | 3 |
Alderson 2005[103] | All | Corticosteroids vs. control | 2008 | 16 | High | 1 | 2 | 0 |
§Meyer 2010[31] | All | Corticosteroids | 1980–2008 | 7 | Low | 1 | 5 | 6 |
§Lu 2012[19] | Adult | Corticosteroids | 2011 | 6 | Low | 1 | 0 | 12 |
12. Surgery | ||||||||
Surgery: compared with no surgery and/or with different surgical techniques | ||||||||
Sahuquillo 2006[104] | All | Decompressive craniectomy | 2008 | 1 | High | 4 | 5 | 0 |
§Meyer 2010[31] | All | Decompressive craniectomy | 1980–2008 | 2 | Mod | 7 | 0 | 1 |
Jacob 2011[105] | Paed. | Decompressive craniectomy** | 1997–2008 | 0 | Low | 0 | 9 | 1 |
Guresir 2012[106] | Paed. | Decompressive craniectomy | 2010 | 0 | Low | 0 | 9 | 1 |
Bor-Seng-Shu 2012[107] | All | Decompressive craniectomy** | 2010 | 1 | Low | 1 | 8 | 0 |
§Lu 2012[19] | Adult | Decompressive craniectomy | 2011 | 3 | Low | 6 | 0 | 1 |
Wang 2015[108] | All | Decompressive craniectomy** | 2015 | 3 | Mod | 2 | 4 | 1 |
Surgery: timing of surgery (n = 10 RCTs in total) | ||||||||
Kim 2014[109] | All | Time to surgery** | 1990–2013 | 2 | Low | 0 | 8 | 0 |
*Post-dates the systematic review: RCT published subsequent to the systematic review, but would otherwise have met the review inclusion criteria (score of 0 means the review is ‘current’)
^Out of scope: RCT did not meet the systematic review inclusion criteria irrespective of when it was published. RCTs that post-dated a review but would not have met the inclusion criteria were coded to this category.
#True Missing: RCT was published within review search dates and looks to have met the review inclusion criteria (score of 0 means the review is ‘complete’)
†Systematic review was judged to be current, complete and high quality
§Multi-intervention review (included more than one intervention type)
**Included one or more outcomes as inclusion criteria
Abbreviations: Conv. = conventional; Corticost. = corticosteroids; CPP = central perfusion pressure; CSF = cerebrospinal fluid; EAAI = excitatory amino acid inhibitors; Endotrach = endotracheal, HTS = hypertonic saline; ICP = intracranial pressure; Includ. = included, Mod. = moderate; Neuroprot = neuroprotective agents; Normo. = normothermia; Normovent. = normoventilation; Paed. = paediatric; PbtO2 = brain tissue oxygen; Pop. = population; PD = post-date the review; Qual. = quality; RBC = red blood cells, RCTs = randomised controlled trials; RSI = rapid sequence intubation; Rx = treatment; S = out of scope; Sm = small, T = true missing, Vs. = versus